NCT00709579View on ClinicalTrials.gov

Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids

PHASE3UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Cortico Atrophy
Interventions
DRUG

RV3391A

A standardized quantity of each product will be applied on the evening on anterior side of forearm. The side of application will be randomized.

DRUG

Placebo

placebo

Trial Locations (1)

31052

Centre Hopitalier Universitaire de Toulouse, Toulouse

Sponsors

Collaborators (1)

Pierre Fabre BIOMETRIE
All Listed Sponsors
collaborator

University Paul Sabatier of Toulouse

OTHER

collaborator

University Hospital, Geneva

OTHER

collaborator

Centre Européen de Recherche sur la Peau,

UNKNOWN

collaborator

Pierre Fabre BIOMETRIE

UNKNOWN

lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT00709579 - Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids | Biotech Hunter | Biotech Hunter